I think @asx11 was just making the point that drugs in the US - as covered by insurers - are multiples in price compared to the cost of drugs covered here in Australia. None of those drugs are actually for axillary hyperhidrosis, but the ones insurers DO cover ALREADY in the US (such as Qbrexza and others) already sell for over $600 and ARE covered by insurance. BOT have discussed their pricing with all the major insurers and they have agreed to BOT's pricing (I thought it was around $700 but happy to be corrected).
BOT - Anything but charting, page-8328
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.8¢ |
Change
0.003(0.77%) |
Mkt cap ! $592.7M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.5¢ | $1.073M | 3.269M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 937760 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 309814 | 10 |
View Market Depth
| Last trade - 14.11pm 11/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |